Are TruAlt Bioenergy Ltd latest results good or bad?

TruAlt Bioenergy Ltd's latest results present a mixed picture. On one hand, the company achieved a remarkable quarter-on-quarter revenue growth of 520.96%, reaching ₹713.24 crores, and returned to profitability with a net profit of ₹69.33 crores, marking a significant increase of 282.74% compared to the previous quarter. This indicates strong operational momentum and recovery in demand.However, the profitability metrics reveal concerning trends. The operating margin has compressed significantly from 30.01% in the same quarter last year to 18.79% this year, and the profit after tax (PAT) margin has also declined from 18.11% to 9.70%. This suggests that while the company is generating more revenue, it is struggling to maintain profitability due to rising costs or operational inefficiencies.Additionally, the year-on-year comparison shows a decline in net profit by 7.79%, which raises concerns about the sustainability of the recent growth. The company's elevated debt levels and weak interest coverage ratio further complicate its financial health.In summary, while the revenue growth is impressive and indicates a recovery, the significant margin compression and declining profitability metrics suggest that the results are not entirely favorable. Investors should be cautious and monitor how the company addresses these challenges moving forward.

Should I buy, sell or hold TruAlt Bioenergy Ltd?

Based on the current situation of TruAlt Bioenergy Ltd, it would be advisable to consider a strong sell recommendation. The company is facing significant challenges, including a high debt level with a debt-to-equity ratio of zero, which indicates a concerning financial structure. Additionally, the company has reported losses, leading to a negative return on capital employed (ROCE).The recent performance is also troubling, with a decline in profit after tax over the last six months, showing a decrease of 44.47%. Furthermore, there has been a reduction in institutional investor participation, which is often a red flag as these investors typically have the resources to assess company fundamentals more effectively than retail investors.TruAlt Bioenergy Ltd has underperformed the market over the past year, generating no return, despite a notable increase in profits. Given these factors, it would be prudent to sell your holdings in the company and look for more stable investment opportunities.

Why is TruAlt Bioenergy Ltd falling/rising?

As of 05-Mar, TruAlt Bioenergy Ltd's stock price is falling, currently at 372.00, which reflects a decrease of 4.3 points or 1.14%. The stock has been on a downward trend, having lost value for the last six consecutive days, resulting in a total decline of 9.49% during this period. Additionally, the stock has underperformed the sector by 2.65% today.In terms of broader performance, the stock has shown negative returns over various time frames, including a 7.94% decline over the past week and an 8.81% drop over the past month. Year-to-date, it has decreased by 7.98%. This consistent underperformance is compounded by the fact that the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.Furthermore, the company faces significant challenges, including high debt levels and reported losses, which contribute to its weak long-term fundamental strength. The debt-to-equity ratio is notably high, and the company has experienced a decline in profit after tax, which fell by 44.47% over the latest six months. Institutional investor participation has also decreased, with a 0.9% reduction in their stake over the previous quarter, suggesting a lack of confidence in the company's prospects.Overall, these factors collectively explain the decline in TruAlt Bioenergy Ltd's stock price.

Why is TruAlt Bioenergy Ltd falling/rising?

As of 06-Mar, TruAlt Bioenergy Ltd's stock price is falling, currently at 368.00, which reflects a decrease of 7.65 (-2.04%). The stock has been on a downward trend, having lost 10.46% over the past seven days and underperforming its sector by 2.8% today. It opened with a loss of 4.14% and reached an intraday low of Rs 360.1. The stock's performance over various periods shows significant declines, with a 1-week drop of 8.17% and a 1-month decline of 14.78%. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Investor participation has also decreased, as evidenced by a 6.53% drop in delivery volume compared to the 5-day average. Furthermore, the company is facing challenges such as high debt levels, with a debt-to-equity ratio averaging at 0 times, and it has reported losses leading to negative return on capital employed (ROCE). Institutional investors have reduced their stakes by 0.9% in the last quarter, reflecting a lack of confidence in the company's long-term fundamentals. Overall, these factors contribute to the stock's decline, highlighting both poor recent performance and underlying financial weaknesses.

TRUALT Share Price | TruAlt Bioenergy Ltd Stock Analysis & Recommendation

Key Events This Week

2 Mar: Sharp 5.68% drop amid broad market weakness

4 Mar: Technical momentum shift to sideways consolidation

5 Mar: Mojo Grade downgraded to Strong Sell with mildly bearish momentum

6 Mar: Continued decline closes week at Rs.367.90

Week Open

Rs.400.75

Week Close

Rs.367.90Read full news article

TruAlt Bioenergy Downgraded to Strong Sell Amid Technical Weakness and Flat Financials

TruAlt Bioenergy Ltd, a player in the Commodity Chemicals sector, has seen its investment rating downgraded from Sell to Strong Sell as of 4 March 2026. This shift reflects deteriorating technical indicators, flat financial performance, and waning institutional interest, signalling caution for investors amid challenging market conditions.

Read full news article

TruAlt Bioenergy Ltd Faces Mildly Bearish Momentum Amid Technical Downgrade

TruAlt Bioenergy Ltd, a player in the Commodity Chemicals sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bearish outlook. Recent technical indicators, including MACD, RSI, and moving averages, suggest increasing downside pressure, prompting a downgrade in its MarketsMOJO grade to Strong Sell as of 4 March 2026.

Read full news article

[ { "link": "quarterly", "btn_text": "All Quarterly Results", "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ", "rhs": [ { "prefix": "Net Sales ", "suffix": "QoQ Growth in quarter ended Dec 2025 is 572.88% vs -64.45% in Sep 2025", "dir": 1 }, { "prefix": "Standalone Net Profit ", "suffix": "QoQ Growth in quarter ended Dec 2025 is 254.43% vs -1,42,600.00% in Sep 2025", "dir": 1 } ], "table": { "header": [ "Dec'25", "Sep'25", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "703.02", "val2": "104.48", "chgp": "572.88%", "chgp_class": "positive" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "129.05", "val2": "-11.79", "chgp": "1,194.57%", "chgp_class": "positive" }, { "field": "Interest", "val1": "39.65", "val2": "38.01", "chgp": "4.31%", "chgp_class": "negative" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "66.02", "val2": "-42.75", "chgp": "254.43%", "chgp_class": "positive" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "18.36%", "val2": "-11.28%", "chgp": "29.64%", "chgp_class": "positive" } ] } }, { "link": "half-yearly", "btn_text": "All Half Yearly Results", "header": "Half Yearly Results Snapshot (Standalone) - Sep'25", "rhs": [ { "prefix": "Net Sales ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 }, { "prefix": "Standalone Net Profit ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 } ], "table": { "header": [ "Sep'25", "Sep'24", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "398.41", "val2": "573.53", "chgp": "-30.53%", "chgp_class": "negative" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "23.10", "val2": "27.23", "chgp": "-15.17%", "chgp_class": "negative" }, { "field": "Interest", "val1": "75.26", "val2": "67.15", "chgp": "12.08%", "chgp_class": "negative" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "-42.72", "val2": "-41.99", "chgp": "-1.74%", "chgp_class": "negative" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "5.80%", "val2": "4.75%", "chgp": "1.05%", "chgp_class": "positive" } ] } }, { "link": "nine-monthly", "btn_text": "All Nine Monthly Results", "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25", "rhs": [ { "prefix": "Net Sales ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 }, { "prefix": "Standalone Net Profit ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 } ], "table": { "header": [ "Dec'25", "Dec'24", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "1,101.43", "val2": "980.84", "chgp": "12.29%", "chgp_class": "positive" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "152.15", "val2": "146.27", "chgp": "4.02%", "chgp_class": "positive" }, { "field": "Interest", "val1": "114.91", "val2": "102.57", "chgp": "12.03%", "chgp_class": "negative" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "23.30", "val2": "30.39", "chgp": "-23.33%", "chgp_class": "negative" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "13.81%", "val2": "14.91%", "chgp": "-1.10%", "chgp_class": "negative" } ] } }, { "link": "annual", "btn_text": "All Annual Results", "header": "Annual Results Snapshot (Standalone) - Mar'25", "rhs": [ { "prefix": "Net Sales ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 }, { "prefix": "Standalone Net Profit ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 } ], "table": { "header": [ "Mar'25", "Mar'24", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "1,880.12", "val2": "1,223.40", "chgp": "53.68%", "chgp_class": "positive" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "297.20", "val2": "188.08", "chgp": "58.02%", "chgp_class": "positive" }, { "field": "Interest", "val1": "141.04", "val2": "143.08", "chgp": "-1.43%", "chgp_class": "positive" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "140.62", "val2": "31.81", "chgp": "342.06%", "chgp_class": "positive" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "15.81%", "val2": "15.37%", "chgp": "0.44%", "chgp_class": "positive" } ] } } ]